Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

DocCheck stock

AJ91.DE
DE000A1A6WE6
A1A6WE

Price

8.10
Today +/-
-0.10
Today %
-1.23 %

DocCheck stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the DocCheck stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the DocCheck stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the DocCheck stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze DocCheck's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

DocCheck Stock Price History

DateDocCheck Price
11/29/20248.10 undefined
11/28/20248.20 undefined
11/27/20248.15 undefined
11/26/20248.15 undefined
11/25/20248.15 undefined
11/22/20248.30 undefined
11/21/20248.20 undefined
11/20/20248.15 undefined
11/19/20248.15 undefined
11/18/20248.35 undefined
11/15/20248.65 undefined
11/14/20248.90 undefined
11/13/20249.10 undefined
11/12/20249.10 undefined
11/11/20249.35 undefined
11/8/20249.35 undefined
11/7/20249.40 undefined
11/6/20249.25 undefined
11/5/20249.20 undefined
11/4/20249.15 undefined

DocCheck Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into DocCheck, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by DocCheck from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects DocCheck’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of DocCheck. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into DocCheck’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing DocCheck’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on DocCheck’s growth potential.

DocCheck Revenue, EBIT and net profit per share

DateDocCheck RevenueDocCheck EBITDocCheck Net Income
202353.41 M undefined3.76 M undefined2.27 M undefined
202260.9 M undefined10.6 M undefined6.29 M undefined
202185.92 M undefined16.87 M undefined11.4 M undefined
202063.1 M undefined14.13 M undefined9.2 M undefined
201932.38 M undefined4.71 M undefined3.14 M undefined
201828.33 M undefined3.9 M undefined2.27 M undefined
201728.07 M undefined3.74 M undefined2.41 M undefined
201625.92 M undefined4.19 M undefined2.66 M undefined
201526.8 M undefined4.01 M undefined2.88 M undefined
201419.89 M undefined2.53 M undefined1.69 M undefined
201317.78 M undefined1.41 M undefined1.09 M undefined
201218.29 M undefined1.55 M undefined1.11 M undefined
201118.03 M undefined1.83 M undefined1.39 M undefined
201015.62 M undefined1.21 M undefined760,000 undefined
200916.46 M undefined1.04 M undefined610,000 undefined
200815.7 M undefined620,000 undefined600,000 undefined
200714.91 M undefined330,000 undefined660,000 undefined
200613.78 M undefined1.1 M undefined910,000 undefined
200511.34 M undefined480,000 undefined640,000 undefined
200410.75 M undefined430,000 undefined650,000 undefined

DocCheck Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0101513131011131415161518181719262528283263856053
--50.00-13.33--23.0810.0018.187.697.146.67-6.2520.00--5.5611.7636.84-3.8512.00-14.2996.8834.92-29.41-11.67
-80.0080.0076.9269.2380.0072.7376.9278.5773.3375.0073.3366.6772.2276.4778.9573.0876.0075.0078.5778.1363.4957.6575.0081.13
081210988101111121112131315191921222540494543
00100000000011112222391162
----------------100.00---50.00200.0022.22-45.45-66.67
-------------------------
-------------------------
4.095.375.95.95.95.925.875.815.75.425.345.314.994.994.994.9955.015.025.025.025.055.075.065.07
-------------------------
Details

Keystats

ⓘ

Revenue and Growth

The DocCheck Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the DocCheck is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (k)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (k)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (k)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                 
0.6126.6428.7130.8210.3531.2117.116.512.8312.310.677.957.285.517.179.59.729.719.3310.699.7920.8222.4916.6518.4
0.492.212.652.091.321.121.42.173.222.521.92.142.182.372.452.683.743.444.233.645.085.98.510.128.09
00.380.10.050.040.040.05000.010.330.440.390.370.830.650.950.850.780.851.612.181.675.094.76
0.30.220.280.220.20.270.410.60.80.840.970.9210.810.971.421.261.151.291.421.763.773.643.353.21
3030307010502050540490140180120200908000000008050
1.4329.4831.7733.2511.9232.6918.9819.3217.3916.1614.0111.6310.979.2611.5114.3315.6715.1515.6316.618.2432.6736.336.0134.46
0.351.21.871.731.391.351.221.361.751.641.432.282.132.021.821.863.163.353.684.266.56.4714.5219.2115.83
00.040.170.1820.350.060.070.072.12.075.227.187.219.17.477.057.0277.296.165.314.935.225.115.57
000000000000000000000003.450
803804002801308090130170140250240250170100200240200210500970900650441.01190.82
3.270.760.790.610.610.710.70.70.720.770.570.290.290.210.210.020.020.020.020.020.020.020.020.020.02
0.041.930.30.350.910.970.580.520.040.060.010.010000.040.120.070.140.370.590.050.020.130.07
3.744.313.533.1523.393.172.662.784.784.687.48109.8811.59.69.1710.5610.6411.3411.3113.3912.3720.4328.3621.68
5.1733.7935.336.435.3135.8621.6422.122.1720.8421.4921.6320.8520.7621.1123.526.2325.7926.9727.9131.6345.0456.7364.3756.14
                                                 
4.085.95.95.95.95.95.95.95.95.345.345.295.294.994.994.994.994.994.994.994.995.035.035.035.07
00000000000000000000000130.890
-0.0325.326.5927.3126.9712.8613.0313.4813.5712.5112.813.1812.5612.4212.5113.214.3615.0415.5115.8417.0325.8832.2833.5432.26
0000000000000000000000010.880
000009030-40-200000000000000000
4.0531.232.4933.2132.8718.8518.9619.3419.4517.8518.1418.4717.8517.4117.518.1919.3520.0320.520.8322.0230.9137.3149.5837.33
0.310.670.530.370.310.270.410.480.670.460.70.490.610.580.610.591.070.681.541.110.921.322.542.31
00000000000.360.30.210.4800000000001.84
0.610.911.181.751.1115.782.32.482.752.141.61.731.961.842.464.155.24.574.315.626.641110.0711.637.94
00000000001901500000000000000
0100201010030201040202010303000000000896
0.921.591.712.141.4316.062.712.993.442.612.892.692.82.913.14.776.275.255.856.737.5612.312.0714.1712.99
0000000000000.050.03000.040.040.030.0300004.96
028080702080100609040504010060150200190240270460560300245.34161.83
0.190.590.840.750.720.6100000000000.060.140.22-0.031.560.836.26.160
0.190.870.920.820.740.690.10.060.090.040.050.040.060.030.060.150.30.370.490.272.021.396.56.415.12
1.112.462.632.962.1716.752.813.053.532.652.942.732.862.943.164.926.575.626.3479.5813.6918.5720.5718.11
5.1633.6635.1236.1735.0435.621.7722.3922.9820.521.0821.220.7120.3520.6623.1125.9225.6526.8427.8331.644.655.8870.1655.44
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of DocCheck provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand DocCheck's financial health and stability.

Assets

DocCheck's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that DocCheck must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of DocCheck after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into DocCheck's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (k)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
001000000000111244334131610
000000000000000000001122
000000000000000000000000
0-200000-100000000-1-1-10-4-5-8-5
0000000000000-1,00000000001,0000-1,000
000000000000000000000000
000000000000000001101174
0-1320110001011123224111105
0-1-100000-100-10000-10-1-2-1-3-4-6
-3-16120-201900-30-3-30-110-20-1000-4-4
-3-14140-202000-10-3-20-11000020201
000000000000000000000000
000000000000000000000000
000000000000-100000000000
4290000-150-1-100-1-1-1-1-1-1-2-2-2-1-5-5
42900000000000-1-1-100000000
000000-1400-100-1000-1-2-2-2-20-5-5
011162-2020-140-30-1-20-1110001-190-4
0-2.952.232.210.490.651.60.11-0.660.581.34-0.651.381.11.132.121.742.011.861.270.748.136.91-0.5
000000000000000000000000

DocCheck stock margins

The DocCheck margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DocCheck. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DocCheck.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the DocCheck's sales revenue. A higher gross margin percentage indicates that the DocCheck retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the DocCheck's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the DocCheck's total revenue generated. When comparing the revenue margin year over year, investors can gauge the DocCheck's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the DocCheck. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the DocCheck's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

DocCheck Margin History

DocCheck Gross marginDocCheck Profit marginDocCheck EBIT marginDocCheck Profit margin
202380.89 %7.05 %4.25 %
202275.17 %17.41 %10.33 %
202157.86 %19.63 %13.27 %
202063.9 %22.39 %14.58 %
201980.23 %14.55 %9.7 %
201879.63 %13.77 %8.01 %
201777.38 %13.32 %8.59 %
201676.27 %16.17 %10.26 %
201572.87 %14.96 %10.75 %
201476.87 %12.72 %8.5 %
201373.79 %7.93 %6.13 %
201272.33 %8.47 %6.07 %
201171.16 %10.15 %7.71 %
201073.82 %7.75 %4.87 %
200974.36 %6.32 %3.71 %
200872.68 %3.95 %3.82 %
200774.78 %2.21 %4.43 %
200675.54 %7.98 %6.6 %
200572.84 %4.23 %5.64 %
200474.6 %4 %6.05 %

DocCheck Stock Sales Revenue, EBIT, Earnings per Share

The DocCheck earnings per share therefore indicates how much revenue DocCheck has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue DocCheck earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates DocCheck's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of DocCheck’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating DocCheck's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

DocCheck Revenue, EBIT and net profit per share

DateDocCheck Sales per ShareDocCheck EBIT per shareDocCheck Earnings per Share
202310.54 undefined0.74 undefined0.45 undefined
202212.03 undefined2.09 undefined1.24 undefined
202116.95 undefined3.33 undefined2.25 undefined
202012.5 undefined2.8 undefined1.82 undefined
20196.45 undefined0.94 undefined0.63 undefined
20185.64 undefined0.78 undefined0.45 undefined
20175.59 undefined0.75 undefined0.48 undefined
20165.17 undefined0.84 undefined0.53 undefined
20155.36 undefined0.8 undefined0.58 undefined
20143.99 undefined0.51 undefined0.34 undefined
20133.56 undefined0.28 undefined0.22 undefined
20123.67 undefined0.31 undefined0.22 undefined
20113.61 undefined0.37 undefined0.28 undefined
20102.94 undefined0.23 undefined0.14 undefined
20093.08 undefined0.19 undefined0.11 undefined
20082.9 undefined0.11 undefined0.11 undefined
20072.62 undefined0.06 undefined0.12 undefined
20062.37 undefined0.19 undefined0.16 undefined
20051.93 undefined0.08 undefined0.11 undefined
20041.82 undefined0.07 undefined0.11 undefined

DocCheck business model

DocCheck AG is a German company that was established in Cologne in 1996. It is the largest European specialist portal for medical professionals and provides various products and services for doctors, pharmacists, and pharmaceutical professionals. Initially, the company focused primarily on offering continuing education for doctors and job placement in the medical field. However, soon the business model expanded and additional sectors were added. An important pillar of the company is the online portal DocCheck.com. Here, medical professionals can register and gain access to exclusive content including specialized articles, studies, and videos, as well as receive updates and news from the medical field. Additionally, the company offers a wide range of medical workwear and accessories. The products range from disposable gloves to stethoscopes and medical torches. The assortment is regularly updated and expanded. Another important area of focus is job placement in the medical sector. DocCheck is one of the largest providers on the German market for medical job advertisements. Employers can place ads for a fee, and job seekers can find suitable job offers. A special highlight for customers is the so-called DocCheck Flexikon. It is an online lexicon for medical terms, continuously revised and updated by specialists. The Flexikon is also available as a smartphone and tablet app. Overall, DocCheck is a company with a wide range of products and services tailored to the needs of medical professionals. In recent years, the company has become an important partner in the healthcare sector in Germany and Europe, and it has become an essential player in the industry. DocCheck is one of the most popular companies on Eulerpool.com.

DocCheck SWOT Analysis

Strengths

  • DocCheck AG has a strong brand reputation and recognition in the healthcare industry.
  • The company offers a comprehensive range of digital solutions and services tailored for healthcare professionals and organizations.
  • DocCheck AG has established a large and loyal customer base, which contributes to stable revenue streams.

Weaknesses

  • The company heavily relies on its digital platform, which makes it vulnerable to potential technological disruptions or cybersecurity threats.
  • DocCheck AG faces competition from other established players in the healthcare technology sector, which may limit its market share.
  • The company's growth is dependent on expanding its customer base and acquiring new markets, which can be challenging in highly regulated healthcare environments.

Opportunities

  • The increasing adoption of digital solutions in the healthcare industry presents an opportunity for DocCheck AG to expand its services and reach a broader market.
  • The company can leverage data analytics and artificial intelligence to develop innovative solutions that improve patient care and operational efficiency.
  • International expansion into new markets with less competition can help DocCheck AG accelerate growth and diversify its revenue streams.

Threats

  • Changing regulatory policies and compliance requirements in the healthcare industry can pose challenges for DocCheck AG's operations and product development.
  • The emergence of new competitors or disruptive technologies may impact the company's market position and profitability.
  • Economic downturns or financial instability could lead to reduced healthcare spending, which could affect the demand for DocCheck AG's services.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

DocCheck Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

DocCheck historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

DocCheck shares outstanding

The number of shares was DocCheck in 2023 — This indicates how many shares 5.068 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue DocCheck earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates DocCheck's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of DocCheck’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating DocCheck's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

DocCheck dividend history and estimates

In 2023, DocCheck paid a dividend amounting to 0.75 EUR. Dividend means that DocCheck distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for DocCheck provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify DocCheck’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating DocCheck's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

DocCheck Dividend History

DateDocCheck Dividend
20230.75 undefined
20221 undefined
20211 undefined
20200.1 undefined
20190.4 undefined
20180.4 undefined
20170.4 undefined
20160.4 undefined
20150.35 undefined
20140.2 undefined
20130.2 undefined
20120.25 undefined

DocCheck dividend payout ratio

In 2023, DocCheck had a payout ratio of 43.47%. The payout ratio indicates the percentage of the company's profits that DocCheck distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for DocCheck represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for DocCheck could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate DocCheck's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

DocCheck Payout Ratio History

DateDocCheck Payout ratio
202343.47 %
202280.46 %
202144.44 %
20205.49 %
201963.49 %
201888.89 %
201783.33 %
201675.47 %
201560.34 %
201458.82 %
201390.91 %
2012113.64 %
201143.47 %
201043.47 %
200943.47 %
200843.47 %
200743.47 %
200643.47 %
200543.47 %
200443.47 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for DocCheck.

DocCheck shareholders

%
Name
Stocks
Change
Date
56.27291 % Antwerpes (Frank)2,832,7116,2369/20/2024
16.21765 % Antwerpes (Pia)816,3776,2909/20/2024
7.82156 % Investmentaktiengesellschaft f¿r Langfristige Investoren TGV393,7282,8939/20/2024
0.79462 % Principal Verm¿gensverwaltung AG40,00040,0002/29/2024
0.15892 % Signal Iduna Asset Management GmbH8,00006/30/2024
0 % pfp Advisory GmbH0-8299/30/2023
0 % BTG Pactual Europe SA0-2,88011/30/2023
0 % Schleber Finanz-Consult GmbH0-3,87812/31/2023
0 % Axxion S.A.0-5,0007/31/2023
1

DocCheck Executives and Management Board

Dr. Frank Antwerpes

DocCheck Chief Executive Officer, Chairman of the Management Board
Compensation 249,996

Mr. Thilo Koelzer

DocCheck Chief Operating Officer, Member of the Management Board
Compensation 244,582

Mr. Philip Stadtmann

DocCheck Chief Financial Officer, Member of the Management Board
Compensation 206,606

Mr. Jens Knoop

DocCheck Chief Technology Officer, Member of the Management Board
Compensation 184,471

Dr. Joachim Pietzko

DocCheck Chairman of the Supervisory Board
Compensation 34,800
1
2

Most common questions regarding DocCheck

What values and corporate philosophy does DocCheck represent?

DocCheck AG represents values such as trust, innovation, and collaboration in the healthcare industry. With a corporate philosophy centered around facilitating communication and knowledge sharing among healthcare professionals, DocCheck AG prioritizes the needs of its users and the quality of their services. Through their platform, they provide a secure environment for doctors, pharmacists, and other medical professionals to connect, exchange information, and access reliable medical content. With a strong focus on digitalization and technology-driven solutions, DocCheck AG aims to enhance the efficiency and effectiveness of healthcare professionals, ultimately improving patient care and outcomes.

In which countries and regions is DocCheck primarily present?

DocCheck AG is primarily present in Germany and serves as a leading provider of online services for the healthcare industry. With a strong focus on the German market, DocCheck AG offers a wide range of innovative products and solutions to medical professionals, pharmaceutical companies, and healthcare organizations. Their comprehensive platform and services enable seamless collaboration and communication within the healthcare community, making it a trusted and preferred choice in Germany's healthcare sector.

What significant milestones has the company DocCheck achieved?

DocCheck AG has achieved significant milestones in its journey as a leading provider in the healthcare industry. The company has successfully established itself as a trusted platform for the exchange of medical knowledge, connecting healthcare professionals worldwide. With a strong focus on innovation, DocCheck AG has developed and launched various solutions to support healthcare providers, such as DocCheck Flexikon, an extensive medical lexicon, and DocCheck News, a platform for up-to-date medical information. Moreover, the company has forged partnerships with renowned institutions and organizations, enabling it to expand its reach and impact within the healthcare community. DocCheck AG continues to revolutionize the medical sector, enhancing communication, and facilitating collaboration among healthcare professionals.

What is the history and background of the company DocCheck?

DocCheck AG is a renowned company with a rich history in the medical industry. Founded in Germany, it has become a leading provider of digital solutions for healthcare professionals. DocCheck's journey began in 1996, and since then, it has focused on developing innovative tools and services to support medical practitioners in their daily work. The company's expertise lies in its comprehensive online platform, which facilitates communication, knowledge sharing, and collaboration among healthcare professionals worldwide. With a strong commitment to quality and reliability, DocCheck AG has earned a solid reputation as a trusted partner in the medical community, continuously striving to enhance medical practice through technological advancements.

Who are the main competitors of DocCheck in the market?

The main competitors of DocCheck AG in the market include Medscape, Doximity, and Epocrates.

In which industries is DocCheck primarily active?

DocCheck AG is primarily active in the healthcare industry.

What is the business model of DocCheck?

The business model of DocCheck AG revolves around providing an online platform and services for healthcare professionals. DocCheck offers a range of products such as DocCheck Login, which enables secure access to medical content, and the Medicus app that allows doctors to access medical information on their mobile devices. Additionally, the company offers DocCheck Shop, an e-commerce platform for medical supplies and equipment. DocCheck AG aims to connect healthcare professionals, facilitate information exchange, and provide convenient solutions for the medical community. Its platform and services play a crucial role in supporting healthcare professionals in their daily work and improving patient care.

What is the P/E ratio of DocCheck 2024?

The P/E ratio cannot be calculated for DocCheck at the moment.

What is the P/S ratio of DocCheck 2024?

The P/S cannot be calculated for DocCheck currently.

What is the Quality Investing of DocCheck?

The Quality Investing for DocCheck is 5/10.

What is the revenue of DocCheck 2024?

The revenue cannot currently be calculated for DocCheck.

How high is the profit of DocCheck 2024?

The profit cannot currently be calculated for DocCheck.

What is the business model of DocCheck

The DocCheck AG is a leading provider of digital services and products in the healthcare industry. The company was founded in 1996 and is headquartered in Cologne. DocCheck's offerings are tailored to doctors, pharmacists, and medical professionals. DocCheck's business model is divided into various segments. One important segment is the digital communication and networking of medical professionals. DocCheck utilizes its own platform, the DocCheck Community, to facilitate exchange between doctors and pharmacists. The platform also offers various features such as news sections, forums, and job opportunities. DocCheck also provides specific apps for certain medical fields, which enable quick and convenient access to important information in the medical field. Another segment of DocCheck is the distribution of medical products needed by doctors and pharmacists. The company offers a wide range of medical products that can be easily ordered online by professionals. DocCheck's product range now also includes medical devices and furnishings for doctor's offices and clinics. A very important service offered by DocCheck is the continued education of medical professionals. For this purpose, the company closely collaborates with the international medical community and offers various e-learning modules and seminars for doctors and pharmacists. The courses are divided into different subjects and ensure that medical professionals stay up to date with the latest advancements in science. Certification for completed courses ensures that the continuing education process is documented and traceable for other industry professionals. DocCheck's business model is based on creating added value for medical professionals. By utilizing the DocCheck platform and the offered services, doctors, pharmacists, and medical professionals can work faster and more effectively and have easier access to important information and products. Through close collaboration with various companies and professionals in the medical industry, DocCheck promotes innovation and development in medical technology. Overall, DocCheck's business model is focused on long-term growth and support for medical professionals. The digital networking and access to important information and products facilitate the work of medical professionals in their everyday lives. With the combination of digital services, distribution, and continued education, DocCheck strengthens the medical industry and the work of medical professionals.

What is the DocCheck dividend?

DocCheck pays a dividend of 1 EUR distributed over payouts per year.

How often does DocCheck pay dividends?

The dividend cannot currently be calculated for DocCheck or the company does not pay out a dividend.

What is the DocCheck ISIN?

The ISIN of DocCheck is DE000A1A6WE6.

What is the DocCheck WKN?

The WKN of DocCheck is A1A6WE.

What is the DocCheck ticker?

The ticker of DocCheck is AJ91.DE.

How much dividend does DocCheck pay?

Over the past 12 months, DocCheck paid a dividend of 0.75 EUR . This corresponds to a dividend yield of about 9.26 %. For the coming 12 months, DocCheck is expected to pay a dividend of 0.75 EUR.

What is the dividend yield of DocCheck?

The current dividend yield of DocCheck is 9.26 %.

When does DocCheck pay dividends?

DocCheck pays a quarterly dividend. This is distributed in the months of June, July, July, June.

How secure is the dividend of DocCheck?

DocCheck paid dividends every year for the past 12 years.

What is the dividend of DocCheck?

For the upcoming 12 months, dividends amounting to 0.75 EUR are expected. This corresponds to a dividend yield of 9.26 %.

In which sector is DocCheck located?

DocCheck is assigned to the 'Health' sector.

Wann musste ich die Aktien von DocCheck kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DocCheck from 6/3/2024 amounting to 0.5 EUR, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did DocCheck pay the last dividend?

The last dividend was paid out on 6/3/2024.

What was the dividend of DocCheck in the year 2023?

In the year 2023, DocCheck distributed 1 EUR as dividends.

In which currency does DocCheck pay out the dividend?

The dividends of DocCheck are distributed in EUR.

All fundamentals about DocCheck

Our stock analysis for DocCheck Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DocCheck Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.